psa prostate cancer vaccine
Vaccineexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2000 (NCT00030602)
Timeline
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- psa prostate cancer vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00015977 | Phase 2 | Nov 1, 2001 | National Cancer Institute (NCI), University of Chicago |
| NCT00005992 | Phase 1 | Dec 1, 2000 | National Cancer Institute (NCI), University of California, Los Angeles |
| NCT00030602 | Phase 2 | Jan 1, 2000 | National Cancer Institute (NCI), University of Maryland |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 3 | 0 | 2 | 2000 |
| University of California, Los Angeles | Academic/Hospital | 1 | 1 | 1 | 2000 |
| University of Chicago | Academic/Hospital | 1 | 1 | 1 | 2001 |
| University of Maryland | Academic/Hospital | 1 | 1 | 1 | 2000 |
4 organizations
Page 1 / 1